Novel nano-siRNA delivery system loaded with anti-ESR1 siRNA for ovarian cancer clinical and nursing value assessment

Metallointercalators-DNA Tetrahedron Supramolecular Self-Assemblies with Increased Serum Stability

(2022) M. Andrey Joaqui-Joaqui et al.   ACS Nano

Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast Cancer

(2022) Wenjuan Ma et al.   ADVANCED MATERIALS

The growth of siRNA-based therapeutics: updated clinical studies

(2021) M. May Zhang et al.   BIOCHEMICAL PHARMACOLOGY

Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence

(2021) Xiu Han et al.   Acta Pharmaceutica Sinica B

Nucleic Acid Delivery for Therapeutic Applications

(2021) Akash Gupta et al.   ADVANCED DRUG DELIVERY REVIEWS

siRNA: Mechanism of action, challenges, and therapeutic approaches

(2021) Walhan Alshaer et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects

(2021) Jianqin Yan et al.   JOURNAL OF NANOBIOTECHNOLOGY

Estrogen Receptors and Endometriosis

(2020) Elodie Chantalat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy

(2020) Ratchanee Duangrat et al.   CANCER SCIENCE

Osthole interacts with an ER‐mitochondria axis and facilitates tumor suppression in ovarian cancer

(2020) Hyocheol Bae et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nucleic acid-based drug delivery strategies

(2020) Xuyu Tan et al.   JOURNAL OF CONTROLLED RELEASE

Ovarian Cancer: An Integrated Review

(2019) Christine Stewart et al.   Seminars in Oncology Nursing

Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

(2019) Hannah J. Vaughan et al.   ADVANCED MATERIALS

Endometriosis-associated ovarian cancer: What have we learned so far?

(2019) M. Herreros-Villanueva et al.   CLINICA CHIMICA ACTA